BeOne Medicines is significantly bolstering its presence in the United States with a substantial $300 million investment earmarked for the…
Read More
AbbVie Invests $1.4 Billion in North Carolina for New Manufacturing Hub
AbbVie, a global biopharmaceutical leader, has announced a landmark $1.4 billion investment to establish its first manufacturing facility in North…
Read More
US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance
The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…
Read More
Canada Invests C$79 Million in Aspect Biosystems to Accelerate Development of Bioengineered Cellular Medicines for Endocrine and Metabolic Diseases
Vancouver, BC – Aspect Biosystems, a pioneering company in the field of bioengineered cellular medicines, has received a significant C$79…
Read More
